SCHEMBL10034977

SCHEMBL10034977

Cc1ccc(N)cc1CF

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
CASP1 P29466 3/20 0.50
TSHR P16473 3/20 0.46
CYP3A4 P08684 2/20 0.46
MAPK1 P28482 2/20 0.44
KMT2A Q03164 2/20 0.44
TAAR1 Q96RJ0 2/20 0.42
PDE10A Q9Y233 1/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
RECQL P46063 1/20 0.39
PRKCI P41743 1/20 0.38
ACHE P22303 2/20 0.37
PLA2G7 Q13093 1/20 0.37
MEN1 O00255 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13069591 0.82 ALDH1A1 (0.52) ALDH1A1CASP1TSHRCYP3A4MAPK1
SCHEMBL2232910 0.81 ALDH1A1 (0.56) ALDH1A1CASP1TSHRCYP3A4MAPK1
SCHEMBL5953121 0.79 ALDH1A1 (0.54) ALDH1A1CASP1TSHRCYP3A4MAPK1
SCHEMBL455280 0.79 ALDH1A1 (0.54) ALDH1A1CASP1TSHRCYP3A4MAPK1
SCHEMBL14448167 0.77 ALDH1A1 (0.52) ALDH1A1CASP1TSHRCYP3A4MAPK1
Ammonia Solution, Strong SCHEMBL10938680 0.77 ALDH1A1 (0.52) ALDH1A1CASP1TSHRCYP3A4MAPK1
SCHEMBL30084985 0.77 TAAR1 (0.69) ALDH1A1CASP1TSHRCYP3A4MAPK1
SCHEMBL792457 0.77 ALDH1A1 (0.52) ALDH1A1CASP1TSHRCYP3A4MAPK1
Hydrochloric Acid SCHEMBL865049 0.77 ALDH1A1 (0.52) ALDH1A1CASP1TSHRCYP3A4MAPK1
SCHEMBL22722975 0.76 TSHR (0.43) ALDH1A1CASP1TSHRCYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012008435-A1 BIARYL AMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 大日本住友製薬株式会社 (JP) 2012-01-19 WO disclosed
US-20110059976-A1 PYRIDO PYRIMIDINONES, DIHYDRO PYRIMIDO PYRIMIDINONES AND PTERIDINONES USEFUL AS RAF KINASE INHIBITORS SUNESIS PHARMACEUTICALS, INC. 2011-03-10 US disclosed
US-7767687-B2 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors BIOGEN IDEC MA INC. (US) 2010-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059976-A1 PYRIDO PYRIMIDINONES, DIHYDRO PYRIMIDO PYRIMIDINONES AND PTERIDINONES USEFUL AS RAF KINASE INHIBITORS BRAF, RAF1, ARAF ALDH1A1 1475/4885CASP1 3251/4885TSHR 1424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.